Business Description
ABL Bio Inc
ISIN : KR7298380007
Share Class Description:
XKRX:298380: Ordinary SharesCompare
Compare
Traded in other countries / regions
298380.Korea IPO Date
2018-12-19Description
ABL Bio Inc is a Korean biotech research company. The company is engaged in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline products include ABL001 an Bispecific Antibody, ABL201-205 an Antibody Drug Conjugate, T cell engager, Dual Immune Cell Targeting BsAb an Immuno-Oncology, ABL301 an BBB-Penetrating Bispecific Antibody.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.53 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-Equity | 0.24 | |||||
| Debt-to-EBITDA | -0.95 | |||||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | 11.57 | |||||
| Beneish M-Score | -1.6 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 97.8 | |||||
| 3-Year EPS without NRI Growth Rate | 59.8 | |||||
| 3-Year FCF Growth Rate | 11.9 | |||||
| 3-Year Book Growth Rate | -7.6 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.66 | |||||
| 9-Day RSI | 39.4 | |||||
| 14-Day RSI | 40.45 | |||||
| 6-1 Month Momentum % | 23.52 | |||||
| 12-1 Month Momentum % | 16.34 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.8 | |||||
| Quick Ratio | 7.8 | |||||
| Cash Ratio | 7.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.2 | |||||
| Shareholder Yield % | -0.16 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -156.1 | |||||
| Net Margin % | -151.73 | |||||
| FCF Margin % | -252.01 | |||||
| ROE % | -53.6 | |||||
| ROA % | -29.16 | |||||
| ROIC % | -43.01 | |||||
| ROC (Joel Greenblatt) % | -75.53 | |||||
| ROCE % | -38.43 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 135.78 | |||||
| PS Ratio | 40.69 | |||||
| PB Ratio | 7.37 | |||||
| Price-to-Tangible-Book | 7.43 | |||||
| EV-to-EBIT | -24.5 | |||||
| EV-to-EBITDA | -25.79 | |||||
| EV-to-Revenue | 37.02 | |||||
| EV-to-FCF | -16.43 | |||||
| Price-to-Net-Current-Asset-Value | 14.46 | |||||
| Price-to-Net-Cash | 14.29 | |||||
| Earnings Yield (Greenblatt) % | -4.08 | |||||
| FCF Yield % | -6.23 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ABL Bio Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 32,321.035 | ||
| EPS (TTM) (â‚©) | -1023 | ||
| Beta | 0.48 | ||
| Volatility % | 62.06 | ||
| 14-Day RSI | 40.45 | ||
| 14-Day ATR (â‚©) | 1792.255487 | ||
| 20-Day SMA (â‚©) | 28232.5 | ||
| 12-1 Month Momentum % | 16.34 | ||
| 52-Week Range (â‚©) | 18960 - 42650 | ||
| Shares Outstanding (Mil) | 48.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ABL Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ABL Bio Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
ABL Bio Inc Frequently Asked Questions
What is ABL Bio Inc(XKRX:298380)'s stock price today?
The current price of XKRX:298380 is â‚©27150.00. The 52 week high of XKRX:298380 is â‚©42650.00 and 52 week low is â‚©18960.00.
When is next earnings date of ABL Bio Inc(XKRX:298380)?
The next earnings date of ABL Bio Inc(XKRX:298380) is 2025-02-12 Est..
Does ABL Bio Inc(XKRX:298380) pay dividends? If so, how much?
ABL Bio Inc(XKRX:298380) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers